KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study

KIF26B has been identified as an oncogene in several tumors; however, its utility as a prognostic indicator for various cancers has not yet been comprehensively evaluated. Here, we first examined how KIF26B intervenes in thirty-three cancers within the TCGA database, including potential immunologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Fei, Lian, Yingying, Wang, Jianlin, Hu, Lijun, Luo, Judong, Yu, Jingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964195/
https://www.ncbi.nlm.nih.gov/pubmed/35359341
http://dx.doi.org/10.1155/2022/4829697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964195/
https://www.ncbi.nlm.nih.gov/pubmed/35359341
http://dx.doi.org/10.1155/2022/4829697

Ejemplares similares